Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis
ID Olaru, J Heyckendorf, S Andres… - European …, 2017 - Eur Respiratory Soc
ID Olaru, J Heyckendorf, S Andres, B Kalsdorf, C Lange
European Respiratory Journal, 2017•Eur Respiratory SocTreatment outcomes for multidrug-resistant (MDR) tuberculosis (TB) are poor with only
approximately 50% of patients attaining treatment success [1]. An important driver of
treatment failure in many settings is the unavailability of effective drugs for MDR-and
extensively drug-resistant (XDR)-TB.
approximately 50% of patients attaining treatment success [1]. An important driver of
treatment failure in many settings is the unavailability of effective drugs for MDR-and
extensively drug-resistant (XDR)-TB.
Treatment outcomes for multidrug-resistant (MDR) tuberculosis (TB) are poor with only approximately 50% of patients attaining treatment success [1]. An important driver of treatment failure in many settings is the unavailability of effective drugs for MDR- and extensively drug-resistant (XDR)-TB.
European Respiratory Society以上显示的是最相近的搜索结果。 查看全部搜索结果